Anti Cancer Medicines

Product Details:

Enzalutamide 40 mg capsules are an oral medication used primarily to treat metastatic castration-resistant prostate cancer (mCRPC). It works by inhibiting androgen receptor signaling, preventing testosterone from stimulating cancer cell growth. Enzalutamide is commonly prescribed for patients with prostate cancer that no longer responds to hormone therapy.

Product Details:

Enzalutamide 40 mg capsules are an oral medication used primarily to treat metastatic castration-resistant prostate cancer (mCRPC). It works by inhibiting androgen receptor signaling, preventing testosterone from stimulating cancer cell growth. Enzalutamide is commonly prescribed for patients with prostate cancer that no longer responds to hormone therapy.

Product Details:

Enzalutamide 40 mg capsules are an oral medication used primarily to treat metastatic castration-resistant prostate cancer (mCRPC). It works by inhibiting androgen receptor signaling, preventing testosterone from stimulating cancer cell growth. Enzalutamide is commonly prescribed for patients with prostate cancer that no longer responds to hormone therapy.

Product Details:

Enzalutamide 40 mg capsules are an oral medication used primarily to treat metastatic castration-resistant prostate cancer (mCRPC). It works by inhibiting androgen receptor signaling, preventing testosterone from stimulating cancer cell growth. Enzalutamide is commonly prescribed for patients with prostate cancer that no longer responds to hormone therapy.

Product Details:

Ibrutinib capsules are used to treat various cancers, including chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenström's macroglobulinemia. It works by inhibiting Bruton's tyrosine kinase, blocking cancer cell growth and promoting cell death in affected lymphocytes.

Product Details:

Erlotinib is an oral targeted therapy used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. It works by inhibiting the epidermal growth factor receptor (EGFR) tyrosine kinase, preventing cancer cell growth. It's effective in patients with EGFR mutations, improving survival and disease progression.

Product Details:

Lapatinib tablets are used to treat advanced or metastatic breast cancer, specifically HER2-positive cancers. They work by inhibiting HER2 receptor signaling, reducing cancer cell growth. Often prescribed alongside other therapies, it improves survival rates and quality of life.

Product Details:

Lapatinib tablets are used to treat advanced or metastatic breast cancer, specifically HER2-positive cancers. They work by inhibiting HER2 receptor signaling, reducing cancer cell growth. Often prescribed alongside other therapies, it improves survival rates and quality of life.

Product Details:

Sorafenib tablets are an oral medication used primarily to treat advanced kidney cancer, liver cancer, and thyroid cancer. It works by inhibiting cancer cell growth and blood vessel formation, slowing tumor progression. It's also used for certain types of hepatocellular carcinoma.

Product Details:

Sorafenib tablets are an oral medication used primarily to treat advanced kidney cancer, liver cancer, and thyroid cancer. It works by inhibiting cancer cell growth and blood vessel formation, slowing tumor progression. It's also used for certain types of hepatocellular carcinoma.

Product Details:

Lapatinib tablets are used to treat advanced or metastatic breast cancer, specifically HER2-positive cancers. They work by inhibiting HER2 receptor signaling, reducing cancer cell growth. Often prescribed alongside other therapies, it improves survival rates and quality of life.

Product Details:

Lapatinib tablets are used to treat advanced or metastatic breast cancer, specifically HER2-positive cancers. They work by inhibiting HER2 receptor signaling, reducing cancer cell growth. Often prescribed alongside other therapies, it improves survival rates and quality of life.

Product Details:

Lapatinib tablets are used to treat advanced or metastatic breast cancer, specifically HER2-positive cancers. They work by inhibiting HER2 receptor signaling, reducing cancer cell growth. Often prescribed alongside other therapies, it improves survival rates and quality of life.

Product Details:

Sorafenib tablets are an oral medication used primarily to treat advanced kidney cancer, liver cancer, and thyroid cancer. It works by inhibiting cancer cell growth and blood vessel formation, slowing tumor progression. It's also used for certain types of hepatocellular carcinoma.

Product Details:

Fludarabine Phosphate Injection is a purine analog used in treating chronic lymphocytic leukemia and certain lymphomas. It inhibits DNA synthesis, leading to cancer cell death. Its precision in targeting malignant cells makes it a key agent in hematologic malignancy management and bone marrow conditioning regimens.

 

Product Details:

Trifluridine and tipiracil is an oral chemotherapy combination used to treat metastatic colorectal and gastric cancers. Trifluridine disrupts cancer cell DNA, while tipiracil enhances its efficacy by preventing degradation. This therapy extends survival in patients unresponsive to standard treatments, offering renewed clinical hope.

 

Product Details:

Cyclophosphamide is a cytotoxic drug for the treatment of malignant disease in adults and children. As a single agent, it has successfully produced an objective remission in a wide range of malignant conditions. Cyclophosphamide is also frequently used in combination with other cytotoxic drugs, radiotherapy or surgery.

Product Details:

Dasatinib tablets are used to treat chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL) by inhibiting BCR-ABL protein, which drives cancer cell growth. It helps reduce cancer cell proliferation, improve survival, and manage leukemia progression.

Product Details:

 

Dasatinib tablets are used to treat chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL) by inhibiting BCR-ABL protein, which drives cancer cell growth. It helps reduce cancer cell proliferation, improve survival, and manage leukemia progression.

 

Product Details:

Lapatinib tablets are used to treat advanced or metastatic breast cancer, specifically HER2-positive cancers. They work by inhibiting HER2 receptor signaling, reducing cancer cell growth. Often prescribed alongside other therapies, it improves survival rates and quality of life.

 

Product Details:

Everolimus tablets are immunosuppressive drugs used to prevent organ rejection after transplants and treat certain cancers (e.g., breast, kidney, pancreatic). They inhibit mTOR, blocking cell growth and proliferation, reducing tumor growth and enhancing graft survival.

 

Product Details:

Everolimus tablets are immunosuppressive drugs used to prevent organ rejection after transplants and treat certain cancers (e.g., breast, kidney, pancreatic). They inhibit mTOR, blocking cell growth and proliferation, reducing tumor growth and enhancing graft survival.

Product Details:

Lenalidomide capsules are an immunomodulatory drug used to treat various conditions, including multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma. It works by enhancing the immune system, inhibiting cancer cell growth, and modulating the tumor microenvironment. Lenalidomide is typically used in combination with other therapies for effective treatment outcomes.

Product Details:

Imatinib tablets are primarily used to treat certain cancers, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). It works by inhibiting specific proteins that promote cancer cell growth, thereby controlling disease progression and improving survival outcomes.

Product Details:

Imatinib tablets are primarily used to treat certain cancers, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). It works by inhibiting specific proteins that promote cancer cell growth, thereby controlling disease progression and improving survival outcomes.

Product Details:

Imatinib tablets are primarily used to treat certain cancers, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). It works by inhibiting specific proteins that promote cancer cell growth, thereby controlling disease progression and improving survival outcomes.

Product Details:

Imatinib tablets are primarily used to treat certain cancers, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). It works by inhibiting specific proteins that promote cancer cell growth, thereby controlling disease progression and improving survival outcomes.

Product Details:

Erlotinib is an oral targeted therapy used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. It works by inhibiting the epidermal growth factor receptor (EGFR) tyrosine kinase, preventing cancer cell growth. It's effective in patients with EGFR mutations, improving survival and disease progression.

Product Details:

Erlotinib is an oral targeted therapy used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. It works by inhibiting the epidermal growth factor receptor (EGFR) tyrosine kinase, preventing cancer cell growth. It's effective in patients with EGFR mutations, improving survival and disease progression.

Product Details:

Ibrutinib capsules are used to treat various cancers, including chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenström's macroglobulinemia. It works by inhibiting Bruton's tyrosine kinase, blocking cancer cell growth and promoting cell death in affected lymphocytes.

Product Details:

Ibrutinib capsules are used to treat various cancers, including chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenström's macroglobulinemia. It works by inhibiting Bruton's tyrosine kinase, blocking cancer cell growth and promoting cell death in affected lymphocytes.

Product Details:

Apalutamide tablets are androgen receptor inhibitors used to treat non-metastatic and metastatic castration-resistant prostate cancer. By blocking androgen signaling, they hinder cancer cell growth and proliferation, offering a targeted, hormone-based therapy that delays disease progression and improves patient outcomes in advanced prostate cancer.

 

Product Details:

Abiraterone Acetate tablets are used primarily to treat metastatic castration-resistant prostate cancer (mCRPC). They work by inhibiting androgen production, which fuels cancer growth. The medication is typically used alongside prednisone to reduce side effects and improve treatment outcomes by controlling tumor progression and alleviating symptoms.

 

Product Details:

Abiraterone Acetate tablets are used primarily to treat metastatic castration-resistant prostate cancer (mCRPC). They work by inhibiting androgen production, which fuels cancer growth. The medication is typically used alongside prednisone to reduce side effects and improve treatment outcomes by controlling tumor progression and alleviating symptoms.

 

Product Details:

ZOLADEX (Goserelin Acetate Implant 10.8 Mg) is a GnRH agonist. Goserelin acetate is chemically described as an acetate salt of [D-Ser(But)6,Azgly10]. Its chemical structure is pyro-Glu-His-Trp-Ser-Tyr-DSer( But)-Leu-Arg-Pro-Azgly-NH2 acetate [C59H84N18O14·(C2H4O2) where x = 1 to 2.4]. Goserelin acetate is an off-white powder with a molecular weight of 1269 Daltons (free base). It is freely soluble in glacial acetic acid. It is soluble in water, 0.1M hydrochloric acid, 0.1M sodium hydroxide, dimethylformamide and dimethyl sulfoxide. Goserelin acetate is practically insoluble in acetone, chloroform and ether. ZOLADEX is supplied as a sterile, biodegradable product containing goserelin acetate equivalent to 3.6 mg of goserelin. ZOLADEX is designed for subcutaneous injection with continuous release over a 28-day period. Goserelin acetate is dispersed in a matrix of D,L-lactic and glycolic acids copolymer (13.3-14.3 mg/dose) containing less than 2.5% acetic acid and up to 12% goserelin-related substances and presented as a sterile, white to cream colored 1-mm diameter cylinder, preloaded in a special single use syringe with a 16-gauge x 36 +/- 0.5 mm siliconized needle with protective needle sleeve (SafeSystem™ Syringe) in a sealed, light- and moisture-proof, aluminum foil laminate pouch containing a desiccant capsule. Studies of the D,L-lactic and glycolic acids copolymer have indicated that it is completely biodegradable and has no demonstrable antigenic potential. ZOLADEX is indicated for use in combination with flutamide for the management of locally confined Stage T2b-T4 (Stage B2-C) carcinoma of the prostate. Treatment with ZOLADEX and flutamide should start 8 weeks prior to initiating radiation therapy and continue during radiation therapy.

Dosage And Administration and Clinical Studies. Prostatic Carcinoma ZOLADEX is indicated in the palliative treatment of advanced carcinoma of the prostate. 
Endometriosis ZOLADEX is indicated for the management of endometriosis, including pain relief and reduction of endometriotic lesions for the duration of therapy. Experience with ZOLADEX for the management of endometriosis has been limited to women 18 years of age and older treated for 6 months.
Endometrial Thinning ZOLADEX is indicated for use as an endometrial-thinning agent prior to endometrial ablation for dysfunctional uterine bleeding. 
Advanced Breast Cancer ZOLADEX is indicated for use in the palliative treatment of advanced breast cancer in pre- and perimenopausal women. At a dose of 3.6 mg, should be administered subcutaneously every 28 days into the anterior abdominal wall below the navel line using an aseptic technique under the supervision of a physician [see Administration Technique]. While a delay of a few days is permissible, every effort should be made to adhere to the 28-day schedule. Stage B2-C Prostatic Carcinoma When ZOLADEX is given in combination with radiotherapy and flutamide for patients with Stage T2b- T4 (Stage B2-C) prostatic carcinoma, treatment should be started 8 weeks prior to initiating radiotherapy and should continue during radiation therapy. A treatment regimen using a ZOLADEX 3.6 mg depot 8 weeks before radiotherapy, followed in 28 days by the ZOLADEX 10.8 mg depot, can be administered. Alternatively, four injections of 3.6 mg depot can be administered at 28-day intervals, two depots preceding and two during radiotherapy. Prostatic Carcinoma For the management of advanced prostate cancer, ZOLADEX is intended for long-term administration unless clinically inappropriate.

Product Details:

Leuprolide Injections are powerful gonadotropin-releasing hormone (GnRH) agonists used to treat hormone-sensitive conditions such as prostate cancer, endometriosis, and uterine fibroids. They work by reducing hormone levels, slowing disease progression, alleviating symptoms, and are also used in managing central precocious puberty in children.

 

Additional Information:

• Production Capacity: NA
• Delivery Time: Immediate
• Packaging Details: Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO¿¿¿s TRIPS agreement to which India is a Signatory. On this page we have made an ¿¿¿Honest Reference¿¿¿ of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.

Product Details:

Apalutamide tablets are androgen receptor inhibitors used to treat non-metastatic and metastatic castration-resistant prostate cancer. By blocking androgen signaling, they hinder cancer cell growth and proliferation, offering a targeted, hormone-based therapy that delays disease progression and improves patient outcomes in advanced prostate cancer.

 

Product Details:

Bortezomib injection is a proteasome inhibitor used to treat multiple myeloma and mantle cell lymphoma. It disrupts cancer cell growth and survival by blocking protein degradation. Administered intravenously or subcutaneously, it is integral to frontline and relapsed/refractory cancer treatment regimens.

 

Product Details:

Sunitinib capsules are used to treat advanced kidney cancer, gastrointestinal stromal tumors (GISTs), and pancreatic neuroendocrine tumors. It works by inhibiting tumor blood vessel growth and blocking cancer cell signals, helping to slow tumor growth and improve survival rates.

Product Details:

Nilotinib tablets are used to treat chronic myelogenous leukemia (CML) by inhibiting the BCR-ABL protein, which drives cancer cell growth. It helps control disease progression, reduce cancer cell proliferation, and improve survival rates in patients with CML.